ProShare Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-18,883
| Closed | -$3.12M | – | 2394 |
|
|
2021
Q2 | $3.12M | Buy |
18,883
+3,769
| +25% | +$629K | 0.01% | 620 |
|
|
2021
Q1 | $2.32M | Sell |
15,114
-969
| -6% | -$132K | 0.01% | 664 |
|
|
2020
Q4 | $2.02M | Buy |
16,083
+348
| +2% | +$38.9K | 0.01% | 633 |
|
|
2020
Q3 | $1.6M | Buy |
15,735
+306
| +2% | +$31.2K | 0.01% | 617 |
|
|
2020
Q2 | $1.5M | Buy |
15,429
+3,225
| +26% | +$300K | 0.01% | 609 |
|
|
2020
Q1 | $1.01M | Sell |
12,204
-8,343
| -41% | -$814K | 0.01% | 599 |
|
|
2019
Q4 | $2.28M | Sell |
20,547
-3,480
| -14% | -$358K | 0.01% | 589 |
|
|
2019
Q3 | $2.38M | Sell |
24,027
-1,264
| -5% | -$126K | 0.01% | 556 |
|
|
2019
Q2 | $2.51M | Sell |
25,291
-4,218
| -14% | -$403K | 0.02% | 545 |
|
|
2019
Q1 | $3.25M | Buy |
29,509
+1,897
| +7% | +$198K | 0.02% | 496 |
|
|
2018
Q4 | $2.54M | Sell |
27,612
-5,467
| -17% | -$553K | 0.02% | 523 |
|
|
2018
Q3 | $3.65M | Buy |
33,079
+636
| +2% | +$66.2K | 0.02% | 497 |
|
|
2018
Q2 | $3.03M | Sell |
32,443
-4,676
| -13% | -$403K | 0.02% | 537 |
|
|
2018
Q1 | $3.08M | Sell |
37,119
-5,731
| -13% | -$509K | 0.02% | 533 |
|
|
2017
Q4 | $3.9M | Buy |
42,850
+3,022
| +8% | +$251K | 0.03% | 478 |
|
|
2017
Q3 | $3.03M | Buy |
39,828
+4,335
| +12% | +$328K | 0.03% | 477 |
|
|
2017
Q2 | $2.66M | Sell |
35,493
-199
| -0.6% | -$13.8K | 0.03% | 495 |
|
|
2017
Q1 | $2.33M | Sell |
35,692
-8,764
| -20% | -$516K | 0.02% | 518 |
|
|
2016
Q4 | $2.45M | Buy |
44,456
+2,859
| +7% | +$157K | 0.03% | 491 |
|
|
2016
Q3 | $2.35M | Sell |
41,597
-6,438
| -13% | -$316K | 0.03% | 447 |
|
|
2016
Q2 | $2.01M | Buy |
48,035
+987
| +2% | +$45.5K | 0.03% | 515 |
|
|
2016
Q1 | $2.01M | Sell |
47,048
-4,285
| -8% | -$181K | 0.03% | 452 |
|
|
2015
Q4 | $2.32M | Buy |
+51,333
| New | +$2.16M | 0.03% | 458 |
|
Other funds holding PRAH
ProShare Advisors's PRAH Position: Q3 2021 in Review
ProShare Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 18,883 shares — an estimated $3.12M sold.
ProShare Advisors first reported a position in PRAH in Q4 2015 and held it in 23 quarters. The position peaked at $3.9M in Q4 2017. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- ProShare Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- ProShare Advisors sold 18,883 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $3.12M.
- ProShare Advisors first reported a position in PRA Health Sciences, Inc. in Q4 2015 and held it in 23 quarters.
- ProShare Advisors's PRA Health Sciences, Inc. position peaked at $3.9M in Q4 2017.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on ProShare Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.